Patents by Inventor Frank Kamiel Delphina Verdonck

Frank Kamiel Delphina Verdonck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KV1.3 binding immunoglobulins
    Patent number: 11149086
    Abstract: The present invention relates to immunoglobulins that specifically bind Kv1.3 and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of Kv1.3.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: October 19, 2021
    Assignee: Ablynx N.V.
    Inventors: Diane Van Hoorick, Erik Depla, Frank Kamiel Delphina Verdonck, Veerle Delanote, Daniel Janssen, Francis Descamps, Mark Edward Labadia, Ann Mikhail, Alisa K. Waterman
  • Biological materials related to HER3
    Patent number: 10808032
    Abstract: The present disclosure relates to amino acid sequences that are directed against (as defined herein) HER3, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences (also referred to herein as “amino acid sequences of the invention”, “compounds of the invention”, and “polypeptides of the invention”, respectively).
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: October 20, 2020
    Assignee: Ablynx NV
    Inventors: Christine Knuehl, Bjoern Hock, Robert Hofmeister, Gerald Beste, Hilde Adi Pierrette Revets, Frank Kamiel Delphina Verdonck, Sigrid Godelieve Victor Cornelis
  • BIOLOGICAL MATERIALS RELATED TO HER3
    Publication number: 20190023796
    Abstract: The present disclosure relates to amino acid sequences that are directed against (as defined herein) HER3, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences (also referred to herein as “amino acid sequences of the invention”, “compounds of the invention”, and “polypeptides of the invention”, respectively).
    Type: Application
    Filed: February 14, 2018
    Publication date: January 24, 2019
    Applicant: Ablynx NV
    Inventors: Christine KNUEHL, Bjoern HOCK, Robert HOFMEISTER, Gerald BESTE, Hilde Adi Pierrette REVETS, Frank Kamiel Delphina VERDONCK, Sigrid Godelieve Victor CORNELIS
  • Biological materials related to HER3
    Patent number: 9932403
    Abstract: The present disclosure relates to amino acid sequences that are directed against (as defined herein) HER3, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences (also referred to herein as “amino acid sequences of the invention”, “compounds of the invention”, and “polypeptides of the invention”, respectively).
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: April 3, 2018
    Assignee: Ablynx NV
    Inventors: Christine Knuehl, Bjoern Hock, Robert Hofmeister, Gerald Beste, Hilde Adi Pierrette Revets, Frank Kamiel Delphina Verdonck, Sigrid Godelieve Victor Cornelis
  • KV1.3 BINDING IMMUNOGLOBULINS
    Publication number: 20170137512
    Abstract: The present invention relates to immunoglobulins that specifically bind Kv1.3 and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of Kv1.3.
    Type: Application
    Filed: June 18, 2015
    Publication date: May 18, 2017
    Applicant: Ablynx N.V.
    Inventors: Diane Van Hoorick, Erik Depla, Frank Kamiel Delphina Verdonck, Veerle Delanote, Daniel Janssen, Francis Descamps, Mark Edward Labadia, Ann Mikhail, Alisa K. Waterman
  • BIOLOGICAL MATERIALS RELATED TO HER3
    Publication number: 20130136748
    Abstract: The present disclosure relates to amino acid sequences that are directed against (as defined herein) HER3, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences (also referred to herein as “amino acid sequences of the invention”, “compounds of the invention”, and “polypeptides of the invention”, respectively).
    Type: Application
    Filed: May 20, 2011
    Publication date: May 30, 2013
    Inventors: Christine Knuehl, Bjoern Hock, Robert Hofmeister, Gerald Beste, Hilde Adi Pierrette Revets, Frank Kamiel Delphina Verdonck, Sigrid Godelieve Victor Cornelis